Literature DB >> 2578268

Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection.

S E Straus, G Tosato, G Armstrong, T Lawley, O T Preble, W Henle, R Davey, G Pearson, J Epstein, I Brus.   

Abstract

Clinical, serologic, virologic, and immunologic evaluations for 31 adults with chronic illness and fatigue suggested that 23 had persisting Epstein-Barr virus infection. Among these 23 patients, cellular immune mechanisms were generally normal, but 4 had mild immunoglobulin deficiencies. However, 20 patients had abnormal serologic profiles specific for Epstein-Barr virus shown by significantly elevated titers of antibodies to the viral capsid antigen or early antigen, or by a deficiency of late-appearing antibodies. In 11 of 15 patients tested, circulating immune complexes were found. Circulating interferon was not found in 18 patients tested, but the activity of 2-5 oligoadenylate synthetase, an interferon-induced enzyme, was increased in 5 patients studied. Of 19 patients, 18 had persisting suppressor T-cell activity typically found in patients recovering from acute infectious mononucleosis. We believe that the Epstein-Barr virus may be associated with chronic illness in adults.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2578268     DOI: 10.7326/0003-4819-102-1-7

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  79 in total

Review 1.  Toward a model of social course in chronic illness: the example of chronic fatigue syndrome.

Authors:  N C Ware
Journal:  Cult Med Psychiatry       Date:  1999-09

2.  NF-kappaB activation stimulates transcription and replication of retrovirus XMRV in human B-lineage and prostate carcinoma cells.

Authors:  Shuhei Sakakibara; Kaori Sakakibara; Giovanna Tosato
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

Review 3.  Recovery from infectious mononucleosis: a case for more than symptomatic therapy? A systematic review.

Authors:  Bridget Candy; Trudie Chalder; Anthony J Cleare; Simon Wessely; Peter D White; Matthew Hotopf
Journal:  Br J Gen Pract       Date:  2002-10       Impact factor: 5.386

Review 4.  The chronic fatigue syndrome.

Authors:  D G James; M G Brook; B A Bannister
Journal:  Postgrad Med J       Date:  1992-08       Impact factor: 2.401

5.  Real-time Epstein-Barr virus PCR for the diagnosis of primary EBV infections and EBV reactivation.

Authors:  Rianne Luderer; Marieke Kok; Hubert G M Niesters; Rob Schuurman; Okke de Weerdt; Steven F T Thijsen
Journal:  Mol Diagn       Date:  2005

6.  Immunologic abnormalities in chronic fatigue syndrome.

Authors:  N G Klimas; F R Salvato; R Morgan; M A Fletcher
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

Review 7.  Chronic fatigue syndrome. A fresh look at an old problem.

Authors:  J McSherry
Journal:  Can Fam Physician       Date:  1993-02       Impact factor: 3.275

8.  The in vitro immunomodulatory effects of glyconutrients on peripheral blood mononuclear cells of patients with chronic fatigue syndrome.

Authors:  D M See; P Cimoch; S Chou; J Chang; J Tilles
Journal:  Integr Physiol Behav Sci       Date:  1998 Jul-Sep

9.  Antibody to Coxsackie B virus in diagnosing postviral fatigue syndrome.

Authors:  N A Miller; H A Carmichael; B D Calder; P O Behan; E J Bell; R A McCartney; F C Hall
Journal:  BMJ       Date:  1991-01-19

Review 10.  Severe chronic active Epstein-Barr virus infection syndrome.

Authors:  M Okano; S Matsumoto; T Osato; Y Sakiyama; G M Thiele; D T Purtilo
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.